Clinical Trial Update: A Study of the Impact of Apremilast (CC-10004) on Quality of Life, Efficacy, and Safety in Adults With Manifestations of Plaque Psoriasis and Impaired Quality of Life [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating apremilast (CC-10004) in adults with plaque psoriasis and impaired quality of life assessed quality of life, efficacy, and safety, wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis
• Psoriasis

Drugs mentioned

• Apremilast (apremilast)

Snippet

Sponsor: Amgen | Conditions: Psoriasis | Phase 4 | Status: COMPLETED | Results posted: 2022-01-13